Your session is about to expire
← Back to Search
VOCALE LBD+ for Caregivers of Persons With Dementia
N/A
Recruiting
Led By Oleg Zaslavsky, PhD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline; 4 weeks, 8 weeks
Awards & highlights
Study Summary
This trial will evaluate an online intervention that helps caregivers of people with Lewy Body Dementia better manage their caregiving responsibilities.
Eligible Conditions
- Caregiver Burden
- Stress
- Coping Skills
- Lewy Body Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline; 4 weeks, 8 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline; 4 weeks, 8 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
A Change From Baseline Caregiving Mastery at 4 and 8 weeks
Trial Design
1Treatment groups
Experimental Treatment
Group I: VOCALE LBD+Experimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Emory UniversityOTHER
1,638 Previous Clinical Trials
2,560,491 Total Patients Enrolled
5 Trials studying Caregiver Burden
378 Patients Enrolled for Caregiver Burden
National Institute on Aging (NIA)NIH
1,672 Previous Clinical Trials
28,018,622 Total Patients Enrolled
24 Trials studying Caregiver Burden
2,474 Patients Enrolled for Caregiver Burden
University of WashingtonLead Sponsor
1,740 Previous Clinical Trials
1,847,629 Total Patients Enrolled
3 Trials studying Caregiver Burden
113 Patients Enrolled for Caregiver Burden
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Family members or other caregivers of a person with Lewy body dementia.
Research Study Groups:
This trial has the following groups:- Group 1: VOCALE LBD+
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the current enrollment rate for this clinical research?
"Affirmative. According to details found on clinicaltrials.gov, this research trial is actively searching for 41 volunteers across 1 institution. Notably, the study was first published and last modified on April 21st 2023."
Answered by AI
Are there still enrollments available for the trial?
"The up-to-date information on clinicaltrials.gov indicates that this medical trial is currently trying to find study participants. This research was first advertised on April 21, 2023 and its details were recently modified in the same day."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger